These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 18367387)

  • 21. First study of the evolution of the SeDeM expert system parameters based on percolation theory: Monitoring of their critical behavior.
    Galdón E; Casas M; Gayango M; Caraballo I
    Eur J Pharm Biopharm; 2016 Dec; 109():158-164. PubMed ID: 27769825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of poorly compactable drug tablets manufactured by direct compression using the mixture experimental design.
    Martinello T; Kaneko TM; Velasco MV; Taqueda ME; Consiglieri VO
    Int J Pharm; 2006 Sep; 322(1-2):87-95. PubMed ID: 16806756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of the Cohesion Index in the SeDeM Diagram Expert System and application of SeDeM Diagram: An improved methodology to determine the Cohesion Index.
    Nofrerias I; Nardi A; Suñé-Pou M; Boeckmans J; Suñé-Negre JM; García-Montoya E; Pérez-Lozano P; Ticó-Grau JR; Miñarro-Carmona M
    PLoS One; 2018; 13(9):e0203846. PubMed ID: 30212557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of automated external lubrication on tablet properties and the stability of eprazinone hydrochloride.
    Yamamura T; Ohta T; Taira T; Ogawa Y; Sakai Y; Moribe K; Yamamoto K
    Int J Pharm; 2009 Mar; 370(1-2):1-7. PubMed ID: 19059327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laser diffraction and image analysis as a supportive analytical tool in the pharmaceutical development of immediate release direct compression formulations.
    Tinke AP; Vanhoutte K; Vanhoutte F; De Smet M; De Winter H
    Int J Pharm; 2005 Jun; 297(1-2):80-8. PubMed ID: 15907597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of SeDeM expert systems in preformulation studies of pediatric ibuprofen ODT tablets.
    Sipos E; Oltean AR; Szabó ZI; Rédai EM; Nagy GD
    Acta Pharm; 2017 Jun; 67(2):237-246. PubMed ID: 28590910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tableting and tablet properties of alginates: characterisation and potential for Soft Tableting.
    Schmid W; Picker-Freyer KM
    Eur J Pharm Biopharm; 2009 May; 72(1):165-72. PubMed ID: 18992337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 7: Formulation and evaluation of ascorbic acid and phenobarbitone tablets.
    Asker AF; Saied KM; Abdel-Khalek MM
    Pharmazie; 1975 Jul; 30(7):466-70. PubMed ID: 1178765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fast-melting tablets based on highly plastic granules.
    Fu Y; Jeong SH; Park K
    J Control Release; 2005 Dec; 109(1-3):203-10. PubMed ID: 16260059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of xylitol on the stability and morphological parameters of tablets with sorbitol made by direct tabletting of formulation components.
    Zgoda MM; Woskowicz M; Nachajski M; Haeusler O; Iwanczyk M
    Pharmazie; 2004 Aug; 59(8):651-3. PubMed ID: 15378860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing disintegration effectiveness: A thorough evaluation using the SeDeM-ODT expert system for doxylamine succinate orodispersible formulation.
    Ahmad SA; Hasan SMF; Bafail D; Shah SF; Imran M; Sahar T; Ishaqui AA
    PLoS One; 2024; 19(9):e0310334. PubMed ID: 39288134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 3: Effect of diluents.
    Asker AF; Saied KM; Abdel-Khalek MM
    Pharmazie; 1975 Jun; 30(6):373-6. PubMed ID: 1161787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of a matrix tablet formulation using a mixture design.
    Waaler PJ; Graffner C; Müller BW
    Acta Pharm Nord; 1992; 4(1):9-16. PubMed ID: 1515056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of two direct compression lactose grades for pyridoxine hydrochloride tablets.
    Aly SA; Udeala OK
    Pharmazie; 1988 Mar; 43(3):188-90. PubMed ID: 3380861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of the SeDeM Expert System in Studies for Direct Compression Suitability on Mixture of Rhodiola Extract and an Excipient.
    Wan S; Yang R; Zhang H; Li X; Gu M; Guan T; Ren J; Sun H; Dai C
    AAPS PharmSciTech; 2019 Feb; 20(3):105. PubMed ID: 30746569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and optimization of a sublingual tablet formulation for physostigmine salicylate.
    Bolourchian N; Hadidi N; Foroutan SM; Shafaghi B
    Acta Pharm; 2009 Sep; 59(3):301-12. PubMed ID: 19819826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of modified starches in direct compression of a poorly water soluble drug (hydrochlorothiazide).
    Okafor IS; Ofoefule SI; Udeala OK
    Boll Chim Farm; 2001; 140(1):36-9. PubMed ID: 11338775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-cyclodextrin as a direct compression excipient compared to conventional ones.
    Saleh SI
    J Pharm Belg; 1993; 48(5):371-7. PubMed ID: 8120790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.